OBJECTIVES: To address the overuse of testing that complicates patient care, diminishes quality, and increases costs by implementing the diagnostic management team, a multidisciplinary system for the development and deployment of diagnostic testing guidelines for hematologic malignancies. METHODS: The team created evidence-based standard ordering protocols (SOPs) for cytogenetic and molecular testing that were applied by pathologists to bone marrow biopsy specimens on adult patients. Testing on 780 biopsy specimens performed during the six months before SOP implementation was compared with 1,806 biopsy specimens performed during the subsequent 12 months. RESULTS: After implementation, there were significant decreases in tests discordant with SOPs, omitted tests, and the estimated cost of testing to payers. The fraction of positive tests increased. Clinicians reported acceptance of the new procedures and perceived time savings. CONCLUSIONS: This process is a model for optimizing complex and personalized diagnostic testing.
OBJECTIVES: To address the overuse of testing that complicates patient care, diminishes quality, and increases costs by implementing the diagnostic management team, a multidisciplinary system for the development and deployment of diagnostic testing guidelines for hematologic malignancies. METHODS: The team created evidence-based standard ordering protocols (SOPs) for cytogenetic and molecular testing that were applied by pathologists to bone marrow biopsy specimens on adult patients. Testing on 780 biopsy specimens performed during the six months before SOP implementation was compared with 1,806 biopsy specimens performed during the subsequent 12 months. RESULTS: After implementation, there were significant decreases in tests discordant with SOPs, omitted tests, and the estimated cost of testing to payers. The fraction of positive tests increased. Clinicians reported acceptance of the new procedures and perceived time savings. CONCLUSIONS: This process is a model for optimizing complex and personalized diagnostic testing.
Authors: Thomas J Wang; Elizabeth A Mort; Paul Nordberg; Yuchiao Chang; Mary E Cadigan; Laura Mylott; Lillian V Ananian; B Taylor Thompson; Michael Fessler; William Warren; Amy Wheeler; Mark Jordan; Michael A Fifer Journal: Arch Intern Med Date: 2002-09-09
Authors: Amit X Garg; Neill K J Adhikari; Heather McDonald; M Patricia Rosas-Arellano; P J Devereaux; Joseph Beyene; Justina Sam; R Brian Haynes Journal: JAMA Date: 2005-03-09 Impact factor: 56.272
Authors: Todd A May; Mary Clancy; Jeff Critchfield; Fern Ebeling; Anita Enriquez; Carmel Gallagher; Jim Genevro; Jay Kloo; Paul Lewis; Rita Smith; Valerie L Ng Journal: Am J Clin Pathol Date: 2006-08 Impact factor: 2.493
Authors: Marten J Poley; Kyra I Edelenbos; Mees Mosseveld; Marc A M van Wijk; Dinny H de Bakker; Johan van der Lei; Maureen P M H Rutten-van Mölken Journal: Clin Chem Date: 2006-12-21 Impact factor: 8.327
Authors: Eric G Neilson; Kevin B Johnson; S Trent Rosenbloom; William D Dupont; Doug Talbert; Dario A Giuse; Allen Kaiser; Randolph A Miller Journal: Ann Intern Med Date: 2004-08-03 Impact factor: 25.391
Authors: Ferrin C Wheeler; Annette S Kim; Claudio A Mosse; Aaron C Shaver; Ashwini Yenamandra; Adam C Seegmiller Journal: Am J Clin Pathol Date: 2018-03-29 Impact factor: 2.493
Authors: Renuka S Bindraban; Maarten J Ten Berg; Christiana A Naaktgeboren; Mark H H Kramer; Wouter W Van Solinge; Prabath W B Nanayakkara Journal: Ann Lab Med Date: 2018-09 Impact factor: 3.464
Authors: Sharyl J Nass; Michael B Cohen; Ritu Nayar; Mary M Zutter; Erin P Balogh; Richard L Schilsky; Hedvig Hricak; Kojo S J Elenitoba-Johnson Journal: Oncologist Date: 2019-07-31
Authors: James M Crawford; Khosrow Shotorbani; Gaurav Sharma; Michael Crossey; Tarush Kothari; Thomas S Lorey; Jeffrey W Prichard; Myra Wilkerson; Nancy Fisher Journal: Acad Pathol Date: 2017-04-18